FDA Inspection 1200400 — Aykut Bayrak, MD A Professional Corporation
The FDA completed an inspection of Aykut Bayrak, MD A Professional Corporation on March 1, 2023 in Los Angeles, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 1, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Los Angeles, CA (United States)